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ABSTRACT 
Objective: The main intention of this research was to formulate and evaluate floating microspheres of ciprofloxacin using different polymers to 
prolong gastric residence time. 
Methods: The microspheres were formulated by the solvent evaporation method using different ratios of polymers like carbopol 940, 
ethylcellulose, and Hydroxy Propyl Methyl Cellulose K4M. Further, the floating microspheres were evaluated for micromeritic properties like bulk 
density, tapped density, angle of repose, etc., percentage yield, particle size, entrapment efficiency, floating capacity, in vitro drug release study, 
release kinetics, drug content, swelling index, and Fourier Transform Infrared Spectroscopy (FTIR) (Compatibility studies). 
Results: The ciprofloxacin microspheres showed the good flowing property. The particle size ranged from 258.1±2.21 µm to 278±2.86 µm and 
entrapment efficiency ranged from 63.17±0.43% to 89.90±1.32%. The IR spectrum revealed that there was no interaction between the drug and 
polymer. F7 formulation was found to be the best formulation. Drug release was found to be 90.70±0.89% i.e. in a controlled manner at the end of 10 h.  
Conclusion: The floating microspheres were prepared successfully and the results clearly stated that prepared ciprofloxacin microspheres may be safe 
and effective controlled drug delivery over an extended period which can increase bioavailability, patient compliance, and decrease dosing frequency.  
Keywords: Ciprofloxacin, Solvent evaporation method, Carbopol 940, Ethylcellulose, Hydroxy propyl methyl cellulose K4M, Floating microspheres 
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INTRODUCTION 
Oral route of administration is one of the most suitable and 
generally used method of drug administration and also the 
development of stomach specified oral controlled release drug 
delivery system is difficult due to the difference in pH in different 
sections of the gastrointestinal tract, the alteration in gastric 
emptying time and also the problem of localizing an oral delivery 
system in a selected location of the gastrointestinal tract. Rapid 
gastrointestinal transit can prevent the absorption of the complete 
drug within the absorption zone and decrease the efficacy of the 
administered dose of the drug since most of the drugs are absorbed 
in the stomach or the upper part of the small intestine. To control 
the above-discussed problems so many types of oral controlled drug 
delivery systems having prolonged gastric residence time have been 
outlined such as floating drug systems, swelling or expanding 
systems, mucoadhesive systems, modified-shape systems, high-
density systems, and more delayed gastric emptying devices [1]. 
Gastroretentive delivery systems are mainly designed for drugs that 
have a narrow absorption window. Such systems get retain at the 
site of absorption and release the drug in a controlled manner for a 
longer time. The floating drug delivery system has drawn much 
attention nowadays due to buoyancy action having greater safety for 
clinical uses and having no effect on the peristaltic movement of the 
GIT. Drugs that have a short half-life require frequent dosing as they 
get eliminated quickly from blood circulation therefore to increase 
the bioavailability of such drugs controlled-release formulations are 
prepared [2]. 
Floating microspheres are gastro retentive drug delivery system based 
on non-effervescent phenomena. It can be also known as hollow 
microspheres, micro-balloons, or floating micro-particles. 
Microspheres are spherical empty particles that don’t have a core. 
These microspheres are free-flowing particles that have a size ranging 
from 1-1000 µm [3]. Ciprofloxacin is an antibiotic, which belongs to 
the fluoroquinolone category and is a broad-spectrum second-
generation antibacterial agent. It is widely used to treat urinary tract 
infections, gram-negative bacterial infections, ophthalmic, skin, bone, 
joint, respiratory, and intra-abdominal infections, periodontal 
pathogens, and bacterial diarrheal infections [4]. The structure of 
ciprofloxacin is shown in fig. 1. The present study has been done to 
formulate floating microspheres of ciprofloxacin with varying drug-
polymer ratios. Ciprofloxacin floating microspheres were prepared to 
obtain prolonged or controlled drug delivery to improve 
bioavailability and to target drug at specific sites.  
 
 
Fig. 1: Structure of ciprofloxacin 
 
MATERIALS AND METHODS 
Materials 
Ciprofloxacin was obtained from Yarrow Chem Products. Carbopol 
940, HPMC K4M were obtained from Research Lab Fine Chem 
Industries, Mumbai. Ethyl Cellulose was obtained from Loba Chemie 
Pvt. Ltd. Mumbai and Cosmo Chem. All other chemicals and reagents 
were of analytical grade which was used. 
Methods 
Calibration curve of ciprofloxacin 
A stock solution of Ciprofloxacin was prepared by dissolving 100 mg 
of the drug in 100 ml of 0.1N Hydrochloric acid (HCl) to attain 1 
mg/ml. From this stock solution, certain dilutions were made with 
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0.1N HCl to achieve certain series of standard solutions of 
concentration containing 1, 2, 3, 4, 5, 6µg/ml. The spectrum of 
standard solutions was run from the 200-400 nm range for 
determination of absorption maximum (λ max) [5, 6].  
Drug-excipient compatibility study 
Before preparation of floating microspheres, drug-excipient 
compatibility was studied using FT-IR spectrophotometer (FTIR-
8400S Shimadzu) [7]. 
Preparation of floating microspheres by Solvent evaporation 
method  
Floating Microspheres containing the antibiotic drug ciprofloxacin 
were prepared by a solvent evaporation method (table 1). In this 
technique, drug and polymer (HPMC K4M, carbopol 940, and 
Ethylcellulose) in various proportions were dissolved in a 20 ml 
acetone which was placed in a small beaker with a magnetic bead on 
the magnetic stirrer at room temperature. The drug-polymer 
mixture was poured into 30 ml liquid paraffin containing Tween 80 
maintained at a temperature of 30-40 °C and subsequently stirred 
by the stirrer at ranging agitation speed i.e. 1200 rpm (revolution 
per minute) for 60 min to allow the volatile solvent to evaporate. 
The microspheres formed were filtered, washed with n-hexane and 
air-dried for 24 h, and stored in a desiccator [8, 9]. 
Characterization of floating microspheres 
The following parameters were determined for the floating 
microspheres of Ciprofloxacin. 
 
Table 1: Composition of ciprofloxacin floating microspheres 
Formulation code F1 F2 F3 F4 F5 F6 F7 F8 F9 
Ciprofloxacin (mg) 100 100 100 100 100 100 100 100 100 
Carbopol 940 (mg) 100 200 300 - - - - - - 
Ethylcellulose (mg) - - - 100 200 300 - - - 
HPMC K4 M (mg) - - - - - - 100 200 300 
Acetone (ml) 20 20 20 20 20 20 20 20 20 




Bulk density is the ratio of the total mass of the powder to the bulk 
volume of powder. It is measured by pouring weighed microspheres of 
about 1g into a measuring cylinder and the bulk volume is noted down. 




Tapped density is the ratio of the total mass of the powder to the 
tapped volume of the powder.  




Hausner’s ratio is the ratio of the tapped density to the bulk density. 
Angle of repose 
The angle of repose (θ) is used to measure the frictional forces in a 
loose powder [10].  
θ = tan
r = Radius of the heap. 
-1h r�  where h = height of the heap 
% Compressibility index  
The percentage compressibility index of powder is the measure of 
potential powder arch or bridge strength and stability. It can be 
calculated as per the following formula, [11]. 
Carr’s Index = Tapped density−Bulk density
Tapped density
 X 100 
Percentage yield 
The percentage yield of the microspheres was determined by 
weighing the prepared microspheres of each formulation divided by 
the total amount of all non-volatile components which were used for 
the preparation of microspheres [12].  
Percentage yield = Actual weight of product
Total weight of drug and polymer
 X 100 
Particle size analysis  
Particle size analysis of drug-loaded floating microspheres was 
performed by optical microscopy. Few microspheres were 
suspended in purified water (10 ml). The sample was placed on a 
clean glass slide and placed on a mechanical stage of the microscope. 
The eyepiece of the microscope fitted with a micrometer and the 
size of the spheres was determined [13].  
Drug entrapment efficiency 
The amount of drug entrapped was determined by crushing the 
microspheres in mortar and pestle. 50 mg was used for the evaluation. 
This was extracted with the aliquots of 0.1N hydrochloric acid (HCl). 
The extract was transferred to100 ml volumetric flask and the volume 
was made up with 0.1N HCl (pH-1.2). The solution was filtered and the 
absorbance was measured spectrophotometrically with suitable 
dilutions at a particular wavelength against the appropriate blank. The 
percent drug entrapped was calculated by the formula which is as 
follows: [14, 15] 
% Entrapment Efficiency = Practical Drug Content
Theoretical Drug Content
 X 100 
Floating capacity 
An in vitro study was carried out to determine floating capacity. 50 
mg floating microspheres were placed in simulated gastric fluid (pH-
1.2, 100 ml) containing tween 20 (0.02w/v %) and stirred on a 
magnetic stirrer at 100rpm. After 12h, the layer of buoyant 
microspheres was separated from the settled microspheres by 
filtration. Microspheres of both types were collected, dried, and 
weighed. The buoyancy of microspheres was determined using the 
following formula; [16]. 
Buoyancy (%) = Wf
Wf+Ws
 X 100 where, W f = Weight of floating 
microspheres 
Ws = Weight of settled microspheres 
In vitro drug release studies 
An in vitro drug release studies were carried out in USP type II 
(Paddle type) dissolution apparatus using simulated gastric fluid 
(pH-1.2) as dissolution medium under sink conditions. Accurately 
weighed samples of floating microspheres were introduced into 900 
ml of dissolution medium maintained at 37±0.5 °C with paddle 
rotating at 100rpm. The adequate samples were withdrawn at the 
interval of 1 hour and the same volume of fresh medium was refilled 
to maintain sink condition. After suitable dilutions, the samples were 
analyzed spectrophotometrically at a specific wavelength. To 
understand the mechanism and kinetics of in vitro drug release 
studies of all formulations were subjected to the goodness of fit test 
by linear regression analysis, according to zero-order and first-order 
kinetics equations, Korsemeyer Peppa’s and Higuchi model [17].  
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Drug content determination  
Drug content was determined using UV-Spectrophotometer. Drug-
loaded microspheres were crushed and 100 mg was suspended in 
100 ml 0.1N HCl solution. This suspended solution was kept for 24h. 
It was stirred for 5 min and filtered. Ciprofloxacin content in the 
filtrate was determined spectrophotometrically at 275 nm using a 
regression derived from the standard curve [9]. 
Swelling index determination 
The swelling index behavior of the floating microspheres was 
measured by studying its weight gain. To determine the swelling 
index the microspheres were kept in the dissolution apparatus using 
the dissolution medium 0.1N HCl at 37±0.5 °C. After 0.5, 1, 2, 3, 4, 5, 
and 6 h, each microsphere from the dissolution apparatus was 
withdrawn, blotted with tissue paper to remove the excess water, 
and weighed on the analytical balance. The experiment was 
performed in triplicate at each time point. The swelling index was 
determined by the following formula; [18] 
Swelling Index = Wet weight of the microspheres−Dry weight of the microspheres
Dry weight of microspheres
 
The cumulative drug release depends on the type and amount of 
polymer used. The polymers used in combination affect the release 
rate [9]. In this research, floating microspheres of ciprofloxacin were 
prepared by carbopol 940, ethylcellulose, and hydroxypropylmethyl 
cellulose (HPMC K4M) by the solvent evaporation method. Polymers 
used individually showed better results as compared in combination 
with other polymers. So individual polymers were used for the 
preparation of ciprofloxacin microspheres. F1 to F3 formulations 
were prepared using carbopol 940, F4 to F6 formulations were 
prepared using ethylcellulose and F7 to F9 formulations were 
formulated using hydroxypropylmethyl cellulose with an increasing 
concentration of polymers. In this research, the drug concentration 
was kept constant. Floating microspheres prepared by solvent 
evaporation were discrete, free-flowing, and spherical in shape.  
RESULTS AND DISCUSSION 
λ max of ciprofloxacin was found at 275 nm. The absorbance of the 
dilutions was measured at 275 nm using 0.1N HCl as blank. A graph 
was plotted by taking absorbance on Y-axis and concentration on X-
axis, which gave a straight line (fig. 2). Values for absorbance are 
shown in table 2.  






1 0 0 
2 1 0.068±0.002 
3 2 0.125±0.001 
4 3 0.237±0.001 
5 4 0.354±0.002 
6 5 0.433±0.001 
7 6 0.522±0.001 




Fig. 2: Calibration curve of ciprofloxacin 
 
Characteristic peaks were observed for the drug as shown in table 3. 
Major functional groups showed characteristic peaks (fig. 3).  
 
Table 3: Characteristic peak value of the ciprofloxacin 
S. No. Group Theoretical peak value (cm-1 Observed peak value (cm) -1) 
1. C-F stretching 1400-1000 1095.60 
2. O-H bending 1300-1250 1288.49 
3. O-H stretching 3300-2500 2638.71 
4. C-O stretching 1450-1400 1435.09 
5. C-H stretching 3300-2800 3286.81 
6. N-H stretching 3700-2500 2700.43 
 
 
Fig. 3: FTIR spectrum of ciprofloxacin 
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The FTIR study was conducted using the FTIR instrument. IR 
spectrum of the pure drug was found to be similar to that of the 
standard IR spectrum of ciprofloxacin. The shift in peak and change 
in the shape of the peak was not observed. Fourier Transform 
Infrared spectra of the drug-polymer mixture indicated that there 
was no interaction between the drug and polymer as shown in fig. 4, 
5, and 6 respectively. Thus carbopol, ethylcellulose, and HPMC K4M 
were chosen for the preparation of floating microspheres. 
 
 
Fig. 4: FTIR spectrum of the mixture (Ciprofloxacin and carbopol 940) 
 
 
Fig. 5: FTIR spectrum of the mixture (Ciprofloxacin and ethylcellulose) 
 
 
Fig. 6: FTIR spectrum of the mixture (Ciprofloxacin and HPMC K4M) 
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All formulations of floating microspheres F1 to F9 were evaluated 
for various micromeritic parameters like bulk density, tapped 
density, Hausner’s ratio, angle of repose, and % compressibility 
index as shown in table 4. The comparison between the bulk density 
and tapped density gives an idea about the interaction in the powder 
such comparison determines the ability of the powder to flow. The 
Hausner’s ratio was found to be in the range of 1.14-1.18 which 
showed good flow property. The angle of repose and % 
compressibility index was also found to be in the range which 
showed the good flowing property. According to the literature, the 
values were in the range which indicated good flow property. This 
suggests that the microspheres can be easily handled during 
processing. The value of Hausner’s ratio of all the formulations was 
below 1.25 which indicated good and better flow properties [19]. 
 
Table 4: Micromeritic properties of floating microspheres 
Formulation code *Bulk density (gm/cm3 *Tapped density (gm/cm) 3 Hausner’s ratio ) *Angle of repose ( °) *Carr’s index 
F1 0.014±0.01 0.016±0.001 1.14 31.92±2.33 14.28±0.02 
F2 0.016±0.01 0.019±0.002 1.18 32.35±1.47 12.00±0.03 
F3 0.022±0.01 0.025±0.001 1.13 35.64±0.91 18.75±0.05 
F4 0.017±0.01 0.020±0.001 1.17 29.68±1.46 17.64±0.01 
F5 0.016±0.01 0.019±0.001 1.18 30.86±2.24 18.75±0.08 
F6 0.020±0.01 0.023±0.002 1.15 33.69±2.56 15.00±0.07 
F7 0.015±0.01 0.017±0.001 1.13 31.89±1.26 13.33±0.05 
F8 0.018±0.01 0.021±0.002 1.16 34.72±1.49 16.66±0.01 
F9 0.018±0.01 0.021±0.001 1.16 30.56±2.76 16.66±0.02 
*Each value is the average of three experiments±Standard Deviation (SD) 
 
Floating microspheres of ciprofloxacin which were prepared by 
the solvent evaporation method were weighed after drying and 
the percentage yield of microspheres containing carbopol 940 is 
less as compared to ethylcellulose and HPMC K4M. The 
percentage yield of microspheres containing ethylcellulose 
(86.00±2.84 to 95.01±1.09) was found to be less as compared to 
HPMC K4M (87.52±2.56 to 96.58±2.23). The floating 
microspheres containing carbopol, ethylcellulose, and HPMC 
K4M showed a percentage yield from 67.50±1.20 to 96.58±2.23. 
Experimentally it can be concluded that % yield value increased 
with increasing polymer concentration (table 5). According to a 
previous study, as the polymer ratio was increased the 
product/percentage yield also increased. The low percentage 
yield in some formulations may be due to the loss of 
microspheres during the washing process [20]. 
 
Table 5: Percentage yield of floating microspheres 










*Each value is the average of three experiments±SD 
 
The particle size of the floating microspheres of ciprofloxacin was 
measured using an optical microscope and was found to be 
increased with an increase in the polymer concentration as shown in 
table 6. The particle size of all formulations was ranged from 
258.1±2.21 µm to 278.2±2.86 µm. The particle size of the 
microspheres increased due to the viscosity of the polymer solution. 
As the viscosity of the polymer increases with increasing polymer 
concentration which results in enhanced interfacial tension 
decreased stirring efficiency and particle size. According to a 
previous study, as the concentration of the polymer was increased, 
the particle size also increased. This is due to the viscosity of the 
polymers used in the formulation. The higher the concentration of 
the polymer solution, the lower was the stirring rate. Due to this 
nature, the polymer rapidly precipitates which leads to hardening 
and avoids a further reduction in the particle size during solvent 
evaporation [21]. 
Table 6: Particle size of microspheres 










*Each value is the average of three experiments±SD 
 
The percent drug entrapment efficiency of ciprofloxacin microspheres 
of all batches was found to be in the range of 63.17±0.43% to 
89.90±1.32%. The entrapment efficiency of HPMC was found to be 
more when the concentration of the polymer was increased in the 
drug: polymer ratio as compared to carbopol and Ethylcellulose as 
shown in table 7. As the polymer concentration is increased more 
particles are coated and which leads to higher entrapment efficiency. 
According to the literature, entrapment efficiency was increased with 
an increase in the polymer concentration. From the results, it can be 
concluded that there is proper distribution of the drug in the 
microspheres and the deviation is within the acceptable limit. As the 
polymer concentration was increased, the entrapment efficiency also 
increased [22]. 
 
Table 7: % Drug entrapment efficiency of floating microspheres 










*Each value is the average of three experiments±SD 
 
The floating capacity of the ciprofloxacin microspheres of all batches 
was ranged from 81.89±1.22% to 95.78±3.68%. As the 
concentration of the polymer was increased the floating capacity of 
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the microspheres also increased as shown in table 8. The increase in 
floating percentage was attributed to air and gel-forming polymer. 
The microspheres prepared by HPMC K4M remained floating for 
more than 15h than the microspheres prepared by carbopol and 
ethylcellulose. According to a previous study, it was reported that as 
the amount of the polymer was increased the floating capacity of the 
microspheres also increased. The increase in the floating capacity 
may be due to air and gel-forming polymer, which causes swelling 
because of the increased amount of polymers [23]. 
 
Table 8: Floating capacity of microspheres 










*Each value is the average of three experiments±SD  
 
The release study of ciprofloxacin floating microspheres was studied 
in simulated gastric fluid (pH 1.2) for 10 h in USP type II dissolution 
apparatus and % drug release is shown in table 9. F1 to F3 
formulations were prepared using carbopol 940 polymer. As the 
carbopol 940 concentration was increased the drug release decreased. 
Drug release ranged from 56.47% (High concentration of carbopol) to 
78.22% (Low concentration of carbopol). Other formulations F4 to F6 
prepared by ethylcellulose gave good release as compared to carbopol. 
But the formulations prepared by HPMC K4M (F7 to F9) gave 
satisfactory release as compared to ethylcellulose and carbopol. Since 
it showed prolonged drug release at the end of 10 h. 
Drug release of the floating microspheres was controlled by the 
polymer. As the polymer concentration (carbopol, ethylcellulose, 
and HPMC) was increased the drug release was decreased 
significantly, as shown in fig. 7. This may be due to the increased 
density of the polymer at higher concentrations which results in 
increased diffusional path length. HPMC helps the dosage form to 
control the release rate at the desired time. The drug release of 
HPMC was found to be more as compared to carbopol and 
ethylcellulose and decreased with an increase in the polymer ratio 
used. F7 formulation showed slow release of the drug, so it was 
considered as an optimized batch prepared by HPMC K4M. 
According to the literature, the cumulative release was decreased 
significantly with an increase in the polymer concentration. The 
increased density of the polymer matrix at higher concentrations 
results in an increased diffusional path length. This may decrease 
the overall drug release from the polymer matrix. Therefore, smaller 
microspheres were formed at lower concentration and have a larger 
surface area exposed to dissolution medium, which gives rise to 
faster release of drug [24]. 
  
Table 9: % Cumulative drug release of floating microspheres 
Time 
in h 
 *Percentage (%) cumulative drug release 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
1 5.00±0.88 4.60±0.97 4.60±1.97 4.59±0.97 4.60±0.78 4.48±0.97 4.60±0.97 5.00±0.97 4.59±0.97 
2 10.41±0.68 9.41±0.90 9.41±1.95 10.21±1.72 9.41±1.90 9.61±0.86 10.81±0.59 10.21±0.72 10.01±0.17 
3 16.42±0.42 14.62±0.74 14.62±1.74 16.62±0.30 14.82±0.75 15.02±0.66 18.21±0.95 16.42±0.35 16.24±0.35 
4 23.02±1.88 20.23±0.50 20.23±1.03 23.62±0.74 21.03±1.32 21.23±0.28 26.42±0.12 23.22±0.38 23.42±0.79 
5 30.23±0.28 26.44±1.12 25.64±1.33 31.03±0.04 27.63±0.85 28.23±0.72 35.62±0.84 30.83±0.14 30.63±0.19 
6 38.03±0.44 33.04±0.65 31.25±1.25 39.03±1.33 35.04±1.21 35.44±1.12 45.61±0.86 39.23±0.28 38.23±0.50 
7 47.03±1.54 40.45±0.11 37.25±0.75 47.36±1.14 43.24±0.39 43.24±0.90 56.21±0.50 48.43±0.23 46.43±0.68 
8 56.83±0.37 48.45±1.23 43.46±1.34 56.83±1.33 51.84±1.47 51.26±0.61 67.21±0.64 58.62±0.97 55.03±0.76 
9 67.23±0.05 56.85±0.36 49.86±0.91 66.23±1.28 61.24±0.39 59.44±0.78 78.60±0.53 69.42±0.57 64.23±0.72 
10 78.22±0.61 68.85±1.36 56.47±1.45 76.23±0.59 71.24±1.16 67.84±0.92 90.79±0.82 81.01±0.99 73.83±0.59 
*Each value is the average of three experiments±SD 
 
 
Fig. 7: Cumulative release of floating microspheres (F1 to F8) 
 
The mechanism of drug release from the microspheres can also be 
studied using kinetic models. The optimized formulation did not 
show any burst-out effect. The dissolution data were subjected to 
regression analysis and were fitted into five kinetic models i.e. zero-
order, first-order, Hixson Crowell, Korsmeyer-Peppa’s, and Higuchi’s 
model. The formulations followed Korsmeyer-Peppa’s model, shown 
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in fig.8. The drug release is evaluated using this model. The n-value 
for the batch was found to be more than 0.89 as shown in table 10, 
which confirmed that the drug release from the system follows 
Super case II transport. According to the literature, n (release 
component) was higher than 0.89 which implies that the drug 
release from the system follows super case II transport [25]. 
 
Table 10: Release rate kinetics of F7 optimized formulation 
Formulation code Zero order (r2 First order (r) 2 Hixson crowell (r) 2 Korsmeyer-peppa’s (r) 2 Higuchi (r) 2) 
F7 0.9919 0.929 0.9807 0.9996 0.9492 
 
 
Fig. 8: Release kinetics plot of F7 formulation 
 
The drug content of all formulations was found to be increased with an 
increase in the concentration of polymer as shown in table 11. As the 
concentration of the polymer is increased more drug particles will be 
bound by the polymers. The drug content also depends on the % yield 
of floating microspheres. HPMC K4M based formulations show higher 
drug content (73.07±2.40 to 83.59±4.86%) as compared to other 
polymer-based formulations. According to the previous study, as the 
polymer concentration in the internal phase was increased the drug 
content also increased. This may be due to an increase in viscosity of 
the internal phase which reduces the migration of the drug in an 
aqueous phase, thus entrapping a greater amount of drugs [26]. 
 
Table 11: Drug content of floating microspheres 











Swelling behaviour also determines the release rate of the drug from 
the dosage form. Greater the swelling capacity greater the release 
rate of the drug from the dosage form. Carbopol containing 
microspheres and ethylcellulose containing microspheres did not 
swell much as compared to HPMC containing microspheres. The 
swelling index of HPMC K4M containing formulations were found to 
be more as compared to other formulations as shown in table 12. 
Ethylcellulose formulations did not swell much as compared to 
carbopol and HPMC. According to a previous study, the greater the 
swelling greater was the release from the microspheres. 
Formulations prepared with ethylcellulose showed no significant 
increase in swelling behaviour. Hydroxypropylmethyl cellulose 
showed greater swelling as compared to ethylcellulose. Percent 
swelling was dependent on water uptake characteristics of the 
polymer as well as polymeric chain relaxation capability [9]. 
 
Table 12: % Swelling index of floating microspheres 










*Each value is the average of three experiments±SD 
 
CONCLUSION 
The floating microspheres of ciprofloxacin were successfully 
prepared using the polymers like carbopol 940, ethylcellulose, and 
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HPMC K4M by the solvent evaporation method. Floating 
microspheres of ciprofloxacin can achieve a prolonged therapeutic 
effect by a controlled release mechanism of the drug for an extended 
of period time in the stomach. The floating microsphere increases 
the gastric residence time as well as bioavailability and decreases 
the dosing frequency of the drug. F7 formulation was found to be the 
optimized formulation due to the controlled release of the drug at 
the end of 10 h. The release was found to be 90.79±0.89%. The 
floating microspheres not only increase the bioavailability of the 
drug it also improves patient compliance.  
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